Carmel Capital Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$209K Buy
990
+9
+0.9% +$1.94K 0.08% 114
2025
Q4
$202K Buy
+981
New +$185K 0.07% 108
2025
Q3
Sell
-3,726
Closed -$626K 116
2025
Q2
$626K Sell
3,726
-243
-6% -$36.1K 0.22% 80
2025
Q1
$547K Hold
3,969
0.22% 82
2024
Q4
$469K Sell
3,969
-188
-5% -$21.9K 0.19% 87
2024
Q3
$459K Buy
4,157
+39
+0.9% +$4.08K 0.18% 93
2024
Q2
$405K Buy
4,118
+88
+2% +$8.97K 0.17% 89
2024
Q1
$451K Sell
4,030
-175
-4% -$18.9K 0.19% 79
2023
Q4
$424K Buy
4,205
+15
+0.4% +$1.49K 0.22% 79
2023
Q3
$364K Buy
4,190
+156
+4% +$14.1K 0.16% 96
2023
Q2
$381K Buy
4,034
+113
+3% +$9.54K 0.2% 81
2023
Q1
$296K Sell
3,921
-265
-6% -$20K 0.18% 99
2022
Q4
$322K Buy
4,186
+467
+13% +$35.5K 0.22% 93
2022
Q3
$248K Buy
+3,719
New +$236K 0.24% 100

Other funds holding CAH

Carmel Capital Partners's CAH Position: Q1 2026 in Review

Carmel Capital Partners increased its Cardinal Health (CAH) stake by 0.92% in Q1 2026, buying an estimated $1.94K and bringing the position to 990 shares worth $209K. The position accounts for 0.08% of the portfolio, ranked #114.

Carmel Capital Partners first reported a position in CAH in Q3 2022 and has held it in 14 quarters since. The position peaked at $626K in Q2 2025. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Carmel Capital Partners held 990 shares of Cardinal Health worth $209K as of Q1 2026.
  • Carmel Capital Partners bought 9 Cardinal Health shares in Q1 2026, an estimated $1.94K.
  • Cardinal Health made up 0.08% of Carmel Capital Partners's portfolio in Q1 2026, its #114 holding.
  • Carmel Capital Partners first reported a position in Cardinal Health in Q3 2022 and has held it in 14 quarters since.
  • Carmel Capital Partners's Cardinal Health position peaked at $626K in Q2 2025.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Carmel Capital Partners's 13F filing for Q1 2026, filed 30 Apr 2026.